FDA Warning Letter — WALMART 402
The FDA took a Warning Letter action against WALMART 402 on Mar 7, 2019 (Breaux Bridge, LA). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- WALMART 402
- Date
- Mar 7, 2019
- Fiscal Year
- 2019
- Product Type
- Tobacco
- Center
- CTP
- Location
- Breaux Bridge, LA (United States)